BONE INDUCTION BY BMP-2 EXPRESSING ADENOVIRAL VECTOR IN RATS UNDER TREATMENT WITH FK506

[1]  H. Nakajima,et al.  In Vivo Osteogenic Capability of Cultured Allogeneic Bone in Porous Hydroxyapatite: Immunosuppressive and Osteogenic Potential of FK506 In Vivo , 2000, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[2]  S. Miyatake,et al.  Osteoinduction by bone morphogenetic protein-2 via adenoviral vector under transient immunosuppression. , 2000, Biochemical and biophysical research communications.

[3]  S. Miyatake,et al.  Expression of bone morphogenetic protein-2 via adenoviral vector in C2C12 myoblasts induces differentiation into the osteoblast lineage. , 1999, Biochemical and biophysical research communications.

[4]  M. Kay,et al.  Inhibition of NF-κB Activation in Combination with Bcl-2 Expression Allows for Persistence of First-Generation Adenovirus Vectors in the Mouse Liver , 1998, Journal of Virology.

[5]  D. Curiel,et al.  Inhibition of tumor necrosis factor alpha decreases inflammation and prolongs adenovirus gene expression in lung and liver. , 1998, Human gene therapy.

[6]  L. Turka,et al.  Blunting of immune responses to adenoviral vectors in mouse liver and lung with CTLA4Ig , 1998, Gene Therapy.

[7]  J. Kolls,et al.  Liver-directed gene transfer in non-human primates. , 1997, Human gene therapy.

[8]  H. Volk,et al.  Nondepleting anti-CD4 antibody treatment prolongs lung-directed E1-deleted adenovirus-mediated gene expression in rats. , 1996, Human gene therapy.

[9]  James M. Wilson,et al.  Role of viral antigens in destructive cellular immune responses to adenovirus vector-transduced cells in mouse lungs , 1996, Journal of virology.

[10]  M. Kaleko,et al.  Transient immunosuppression permits successful repetitive intravenous administration of an adenovirus vector. , 1996, Gene therapy.

[11]  Y. Kanegae,et al.  Efficient generation of recombinant adenoviruses using adenovirus DNA-terminal protein complex and a cosmid bearing the full-length virus genome. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[12]  S. Sugano,et al.  Efficient gene activation in mammalian cells by using recombinant adenovirus expressing site-specific Cre recombinase. , 1995, Nucleic acids research.

[13]  K. Tamura.  FK506: mechanism of immunosuppression and adverse-effects. , 1995, The Journal of toxicological sciences.

[14]  H. V. Connerty,et al.  Determination of serum calcium by means of orthocresolphthalein complexone. , 1966, American journal of clinical pathology.